Ribomic Inc. (TYO:4591)

Japan flag Japan · Delayed Price · Currency is JPY
82.00
-1.00 (-1.20%)
At close: Feb 6, 2026
-1.20%
Market Cap4.45B +25.5%
Revenue (ttm)n/a
Net Income-1.05B
EPS-23.78
Shares Out54.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume316,900
Average Volume800,115
Open83.00
Previous Close83.00
Day's Range82.00 - 83.00
52-Week Range72.00 - 141.00
Beta0.26
RSI43.58
Earnings DateFeb 12, 2026

About Ribomic

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. The company was incorporated in 2003 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 25
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4591
Full Company Profile

Financial Performance

Financial Statements